(19)
(11) EP 2 887 068 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.10.2018 Bulletin 2018/43

(45) Mention of the grant of the patent:
15.08.2018 Bulletin 2018/33

(21) Application number: 13306815.5

(22) Date of filing: 20.12.2013
(51) International Patent Classification (IPC): 
G01N 33/569(2006.01)

(54)

Method for improving the diagnosis of invasive Candida infections by FBA1 protein detection

Verfahren zur Verbesserung der Diagnose von invasiven Candida-Infektionen durch FBA1-Proteinerkennung

Procédé pour améliorer le diagnostic d'infections invasives par Candida via la détection d'une protéine FBA1

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(43) Date of publication of application:
24.06.2015 Bulletin 2015/26

(73) Proprietors:
  • Bio-Rad Innovations
    92430 Marnes-La-Coquette (FR)
  • Centre Hospitalier Universitaire de Lille
    59000 Lille (FR)
  • Université de Lille
    59800 Lille (FR)

(72) Inventors:
  • Damiens, Sébastien
    59470 Merckeghem (FR)
  • Tabouret, Marc Charles Victor
    59320 Ennetieres en Weppes (FR)
  • Sendid, Boualem
    59120 Loos (FR)
  • Poulain, Daniel
    59242 Templeuve (FR)
  • Fradin Chantal
    59000 Lille (FR)

(74) Representative: Lavoix 
2, place d'Estienne d'Orves
75441 Paris Cedex 09
75441 Paris Cedex 09 (FR)


(56) References cited: : 
   
  • AIDA PITARCH ET AL: "Proteomics-based identification of novelCandida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies", PROTEOMICS, vol. 4, no. 10, 1 October 2004 (2004-10-01), pages 3084-3106, XP055036868, ISSN: 1615-9853, DOI: 10.1002/pmic.200400903
  • PONTON JOSE ET AL: "Advances and limitations in the early diagnosis of invasive yeasts infections", REVISTA IBEROAMERICANA DE MICOLOGIA, vol. 24, no. 3, September 2007 (2007-09), pages 181-186, XP002682704, ISSN: 1130-1406
  • ANANE ET AL: "Diagnostic biologique des candidoses systemiques : difficultes et perspectives", PATHOLOGIE ET BIOLOGIE, L'EXPANSION SCIENTIFIQUE FRANCAISE, PARIS, FR, vol. 55, no. 5, 1 June 2007 (2007-06-01), pages 262-272, XP022113786, ISSN: 0369-8114, DOI: 10.1016/J.PATBIO.2006.03.003
  • FANG-QIU LI ET AL: "Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia", BMC INFECTIOUS DISEASES, BIOMED CENTRAL, LONDON, GB, vol. 13, no. 1, 31 May 2013 (2013-05-31), page 253, XP021152048, ISSN: 1471-2334, DOI: 10.1186/1471-2334-13-253
  • PITARCH AIDA ET AL: "Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum.", MOLECULAR & CELLULAR PROTEOMICS : MCP JAN 2011, vol. 10, no. 1, January 2011 (2011-01), XP002725138, ISSN: 1535-9484
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).